Hwaseong-si, South Korea

Dong Jin Hong



Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Dong Jin Hong

Introduction

Dong Jin Hong is a prominent inventor based in Hwaseong-si, South Korea. With a passion for innovation, he has contributed significantly to the field of pharmaceuticals, particularly through his patented work on dioxoloisoquinolinone derivatives. His groundbreaking research presents potential advancements in the medical field.

Latest Patents

Dong Jin Hong holds a patent for "Dioxoloisoquinolinone derivatives and use thereof." This innovative patent discloses novel dioxoisoquinolinone derivatives, including pharmaceutically acceptable salts, optical isomers, hydrates, and solvates. The compounds developed by Hong exhibit inhibition activity of EZH1 (Enhancer of zeste homolog 1) and EZH2 (Enhancer of zeste homolog 2) activity, making them valuable in creating effective pharmaceutical compositions.

Career Highlights

Throughout his career, Dong Jin Hong has been recognized for his expertise and dedication within Hanmi Pharmaceutical Co., Ltd. His work reflects a deep commitment to advancing medicinal chemistry and finding solutions for various health issues through innovative drug development.

Collaborations

In his journey of innovation, Dong Jin Hong has collaborated with esteemed colleagues such as Seung Hyun Jung and Ji Young Hwang. These collaborative efforts have proven fruitful in fostering an environment of creativity and scientific exploration, leading to significant advancements in their field.

Conclusion

Dong Jin Hong's contributions to the pharmaceutical industry highlight the importance of innovation in developing new therapeutic options. His ongoing research and dedication to advancing pharmaceutical sciences continue to make a marked impact within the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…